Shaji Kumar
@myelomaMD
Followers
9K
Following
114
Media
27
Statuses
512
Professor of Medicine, Chair, Myeloma, Amyloidosis, Dysproteinemia Group @mayoclinic. My tweets reflect my personal opinion
Joined May 2011
NEWS: We are excited to announce that the first patient has been dosed in the Phase 3 study evaluating an investigational BCMA-directed bispecific antibody for patients with relapsed/refractory #MultipleMyeloma. Read more: https://t.co/n9RanaEqo2.
@PlasmaCellPete #mmsm
0
9
21
A well-deserved honor!
A heartfelt thanks to Nikhil Munshi for all your contributions to the International Myeloma Society and the myeloma community. It is with great honor to announce Philippe Moreau as the new International Myeloma Society President. #IMS23
0
3
26
We are about to start #ASH22 Friday symposium on myeloma. @CCO_Education @IMFmyeloma Philippe Moreau, @myelomaMD @YiLinMDPhD @VincentRK Jesus San Miguel and @TomBmt133
9
13
105
@IreneGhobrial This is a very unfair statement. There are 8 sessions. In 7 of the 8 sessions there are women academic colleagues. The program overall has 25 men and 21 women panelists. The myeloma community is very diverse and inclusive. Let’s not divide it.
2
3
53
NCI myeloma steering committee consensus on relapsed myeloma. Authored by investigators who design & conduct US randomized trials. @BloodCancerJnl @myelomaMD @NoopurRajeMD @nsc_natalie @andrew02114 @SLentzsch @PLMcCarthyMD @theNCI #OpenAccess
3
20
51
How should we tackle the challenges of managing relapsed myeloma https://t.co/JgbqUcXQwp
1
14
44
0
10
15
Preview of the upcoming 5th edition of the World Health Organization Classification of Hematologic Cancers (WHO Blue Book) is now published in @LeukemiaJnl as two papers. Check it out. #MedTwitter 1/ Lymphoid/Plasma cell neoplasms Open Access link: https://t.co/P2bTkH8kq8
1
30
62
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie
https://t.co/VtBMJUjI5X Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
0
4
6
Ph3 Len +/- Ixa maintenance for MRD+ s/p ASCT -> #EAOnc EAA171 - Optimizing Prolonged Treatment In Myeloma Using MRD assessment (OPTIMUM) [Activation: Jun 1, 2021] https://t.co/4TRHkoLglI PI= @myelomaMD #NCT03941860 @eaonc #mmMRD #mmsm #bmtsm n=510
0
3
5
#Clinicaltrial EAA171/OPTIMUM’s objective is to determine if the addition of ixazomib to lenalidomide improves overall survival for those with previously diagnosed #multiplemyeloma. Learn more here: https://t.co/zGTsDl8ReB
#mmsm cc: @myelomaMD @mtmdphd @VincentRK
0
5
4
Interested in an academic career in #myeloma, #amyloidosis? Apply for an Advanced Fellowship @MayoMyeloma You can develop your clinical expertise in caring for our patients while engaging in exciting and novel clinical and translational research. Apply@
college.mayo.edu
1
10
24
This study is a multi-center phase 2 study of carfilzomib, lenalidomide, daratumumab, and dexamethasone in subjects with high-risk smoldering multiple #myeloma (SMM). https://t.co/WBQ2cbauMU
#clinicaltrial #mmsm
0
3
5
Your donation towards a histopathology lab at our #Nepal #cancer center could help provide faster care to 5000 patients per year Please consider donating at https://t.co/4WUG2JmIz6
@myelomaMD @SidYadavMD @AboulafiaMd @doctorC369 @agrothey @binayshah
0
5
8
Multiple Myeloma ~#ASH20Top10 #mmsm #mmMRD #ASH20 @mtmdphd Table Update: 12/1/20 --@AuclairDan @bdermanmd @DrOlaLandgren @End_myeloma @jmikhaelmd @myelomaMD @ninashah33 @Phari @rajshekharucms @Rfonsi1 @sykristinsson @SusanBal9 @szusmani @VincentRK - cc @grpetersen1
0
11
27